About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 870 record(s)
Req # A-2023-000981
The Health Canada indication for Medical Device License (MDL) 69955, specifically, the Contour branded indication, Manufacturer PROLLENIUM MEDICAL TECHNOLOGIES INC.Organization: Health Canada
May 2024
Req # A-2023-001536
As part of its application to Health Canada for authorization to sell the COVID-19 lateral flow device with the Interim Order (IO) authorization Identification 327866, the manufacturer sent the federal government about 200 sample tests. Provide the report that the Health Canada team led by the Director General received from the National Microbiology Laboratory on the test's accuracy and considered as they evaluated the application, approving it on October 20, 2021.Organization: Health Canada
May 2024
Req # A-2023-001537
As part of its application to Health Canada for authorization to sell the three COVID-19 lateral flow devices with the Interim Order (IO) authorization Identifications 313054, 328889, and 333956, the manufacturer sent the federal government about 200 sample tests for each one. Provide the reports that the Health Canada team led by the Director General received from the National Microbiology Laboratory on the tests' accuracy andconsidered as they evaluated the applications, approving the three devices respectively in February, June and December 2021.Organization: Health Canada
May 2024
Req # A-2022-001452
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-075408-992, Deputy Ministerial Meeting with DNAStack.Organization: Health Canada
May 2024
Req # A-2023-001583
Adverse Drug Reaction (ADR) for Isentress. Report number: E2B_ 00310522.Organization: Health Canada
May 2024
Req # A-2022-000519
All data from Health Canada on effects of 5G on human health, especially on children. Relevant records from January 2017 to June 2022.Organization: Health Canada
April 2024
Req # A-2023-000069
All current Health Canada approved labelling for: - LASER SYSTEMS, Medical Device Licence # 87286 CUTERA, INC. 3240 Bayshore Boulevard Brisbane, California, United States, 94005.Organization: Health Canada
April 2024
Req # A-2023-000071
Currently approved Intended use for the: - EXCEL V LASER, Medical Device Licence # 87286 CUTERA, INC. 3240 Bayshore Boulevard Brisbane, California, United States, 94005Organization: Health Canada
April 2024
Req # A-2020-000450
Adverse Drug Reaction (ADR). Report number: E2B_03076104.Organization: Health Canada
April 2024
Req # A-2020-000938
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-108812-88, Deputy Minister’s Meeting with Canada’s new Auditor General.Organization: Health Canada
April 2024